Eczema, Attention and ADHD: An Association Is a Reason to Assess, Not Assume
DOCTOR’S NOTES · ECZEMA EVIDENCE
When a child with eczema seems restless or distracted, the answer should not be guessed from the rash. Eczema can coexist with ADHD, while poor sleep and other problems can produce overlapping difficulties. The practical goal is to understand the child's experience across home and school and arrange an appropriate assessment.
What a 49-study review found
A 2025 systematic review, searching literature through March 11, 2024, included 49 observational studies. Analyses found an association between atopic dermatitis and ADHD: the pooled odds ratio was 1.34, with a 95% confidence interval of 1.25–1.44. A separate pooled hazard-ratio analysis was 1.42, with a confidence interval of 1.20–1.68. These measures come from different study designs and should not be blended into one personal probability.
The review also examined the reverse association and subgroups. However, observational associations cannot show that eczema causes ADHD or that treating eczema prevents it. Diagnostic methods, populations, accompanying allergic conditions and sleep problems complicate interpretation. A statistically supported association is not an ADHD screening test.
Why “34%” does not mean 34 out of 100 children
An odds ratio of 1.34 describes relative odds in the included data. It does not say that 34% of children with eczema have ADHD. Without an appropriate baseline probability and compatible study design, converting it into an individual risk would be misleading. Nor does the number tell a parent why their own child is struggling.
| Observation to bring | A useful question |
|---|---|
| Difficulties at home and school | How consistent are the concerns across settings? |
| Itch-related awakenings or snoring | Could a sleep problem be contributing? |
| Time pattern around medicines | Should the full medication list be reviewed? |
| Learning, hearing or vision concerns | Which other assessments are appropriate? |
Assess attention and sleep together
The CDC describes ADHD diagnosis as a multistep process, with no single diagnostic test. Providers gather information from parents, teachers and other caregivers, and consider conditions that can resemble or coexist with ADHD. Sleep disorders, anxiety and learning difficulties are among the possibilities. A child can have more than one need, so checking sleep does not mean dismissing persistent attention symptoms.
NIAMS lists sleep loss among eczema-associated problems. Our article on a child with eczema who snores discusses a particular sleep question; snoring should not automatically be attributed to itchy skin. Our antihistamine and drowsiness guide explains why the medicine list matters too.
Make the school conversation descriptive
Ask teachers for concrete examples rather than labels such as “lazy” or “not trying.” Which tasks are difficult? Does the child miss instructions, leave work unfinished or struggle after a poor night? Are similar difficulties present during enjoyable activities or only when the skin is painful? These details help a clinician understand impact without expecting a teacher to diagnose a medical condition.
Do not wait for perfect eczema control before mentioning ongoing developmental or learning concerns. Likewise, an attention assessment should not delay appropriate care for disrupted sleep or active eczema. Agree on who will coordinate information and how the family will hear the findings. The child deserves support without being told that a rash determines their personality or future.
Where everyday moisture care fits
Dr. Arsy Moisturizer #003, 4 oz (120 g) is a cosmetic moisturizer for hydration and moisture-barrier support. It does not treat, cure or prevent eczema and was not the intervention in the medical studies above. For a baby or child, ask their clinician which moisturizer is appropriate. The research discussed here does not establish infant suitability or pediatric efficacy for #003.
If the family also has concerns about height or growth patterns, discuss those specifically. Questions about topical steroids and adrenal testing concern a different clinical assessment and should not be inferred from attention symptoms.
Sources and research
- 2025 systematic review: bidirectional eczema–ADHD associations
- CDC: diagnosing ADHD
- NIAMS: atopic dermatitis and associated problems
Prepared by the Dr. Arsy editorial team. Sources checked November 8, 2026. Educational content does not diagnose an individual or imply independent clinician review. The cited researchers and institutions do not endorse #003. Image is an AI-created product illustration, not a patient image or clinical result.